Structure |
Chemical Name |
CAS |
MF |
![Solifenacin impurity 17](/CAS/20200515/GIF/1029430-94-1.gif) |
Solifenacin impurity 17 |
1029430-94-1 |
C19H17N3O |
![Sugammadex sodium Org205485-1 Impurity](/) |
Sugammadex sodium Org205485-1 Impurity |
|
|
![Sugammadex sodium Org246653-1 Impurity](/) |
Sugammadex sodium Org246653-1 Impurity |
|
|
![Tadalafil impurity R](/) |
Tadalafil impurity R |
|
|
![N-((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl) sulfonyl)acetamide](/CAS/20200401/GIF/198471-47-5.gif) |
N-((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl) sulfonyl)acetamide |
198471-47-5 |
C19H16F3N3O3S |
![Butyphthalide impurity 29](/) |
Butyphthalide impurity 29 |
|
|
![Butyphthalide impurity 38](/CAS/20210111/GIF/1841089-56-2.gif) |
Butyphthalide impurity 38 |
1841089-56-2 |
C24H30O5 |
![Canagliflozin Impurity 39](/) |
Canagliflozin Impurity 39 |
|
|
![Cefaclor double bond displacement impurity 9](/) |
Cefaclor double bond displacement impurity 9 |
|
|
![Diquafosol Impurity 7](/) |
Diquafosol Impurity 7 |
|
|
![Febuxostat Impurity 75](/) |
Febuxostat Impurity 75 |
|
|
![Febuxostat Impurity 90](/) |
Febuxostat Impurity 90 |
2646683-37-4 |
|
![Febuxostat Impurity 95](/) |
Febuxostat Impurity 95 |
|
|
![Ibrutinib Impurity 17](/CAS/20210305/GIF/2134109-10-5.gif) |
Ibrutinib Impurity 17 |
2134109-10-5 |
C16H18N6O |
![LCZ696(valsartan + sacubitril) impurity 36](/) |
LCZ696(valsartan + sacubitril) impurity 36 |
|
|
![Lenvatinib Impurity 17](/) |
Lenvatinib Impurity 17 |
|
|
![Moxifloxacin degradation impurity 36](/) |
Moxifloxacin degradation impurity 36 |
|
|
![Moxifloxacin Impurity 49](/) |
Moxifloxacin Impurity 49 |
|
|
![Alvimopan Impurity 2](/) |
Alvimopan Impurity 2 |
|
|
![Alvimopan Impurity 4](/) |
Alvimopan Impurity 4 |
|
|
![Isavuconazole Impurity 13](/) |
Isavuconazole Impurity 13 |
|
|
![Sofosbuvir Impurity13](/CAS/20200611/GIF/220503-64-0.gif) |
Sofosbuvir Impurity13 |
220503-64-0 |
C38H31N3O9 |
![21-Acetyl-6β-fluorotriamcinolone Acetonide](/CAS/20210111/GIF/67438-37-3.gif) |
21-Acetyl-6β-fluorotriamcinolone Acetonide |
67438-37-3 |
C26H32F2O7 |
![Quetiapine EP Impurity W](/CAS/20180808/GIF/1800608-95-0.gif) |
Quetiapine EP Impurity W |
1800608-95-0 |
C34H32N4O2S2 |
![1,1,4,4-テトラフェニル-L-トレイトール](/CAS/20180629/GIF/117780-08-2.gif) |
1,1,4,4-テトラフェニル-L-トレイトール |
117780-08-2 |
C28H26O4 |
![(11β,16α)-21-(Acetyloxy)-11,16,17-trihydroxypregna-1,4,14-triene-3,20-dione](/CAS/20211123/GIF/131918-72-4.gif) |
(11β,16α)-21-(Acetyloxy)-11,16,17-trihydroxypregna-1,4,14-triene-3,20-dione |
131918-72-4 |
C23H28O7 |
![O-Acetyl Silodosin](/CAS/20180808/GIF/160970-86-5.gif) |
O-Acetyl Silodosin |
160970-86-5 |
C27H34F3N3O5 |
![Olaparib Impurity I](/) |
Olaparib Impurity I |
|
|
![Brexpiprazole Impurity C](/) |
Brexpiprazole Impurity C |
|
|
![Dapoxetine Impurity 7](/) |
Dapoxetine Impurity 7 |
|
|
![Irbesartan Impurity 5](/CAS/20200331/GIF/CB23127104.gif) |
Irbesartan Impurity 5 |
1213252-81-3 |
C25H28N6O |
![Cabozantinib impurity C](/) |
Cabozantinib impurity C |
|
|
![Loratadine Impurity 4](/CAS/20200331/GIF/CB23127513.gif) |
Loratadine Impurity 4 |
|
C22H23ClN2O2 |
![Metoprolol IMpurity 4](/CAS/20200331/GIF/CB23127588.gif) |
Metoprolol IMpurity 4 |
|
C15H25NO3 |
![Mirabegron Impurity 10](/) |
Mirabegron Impurity 10 |
|
|
![8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one](/CAS/20180629/GIF/1376615-91-6.gif) |
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one |
1376615-91-6 |
C24H31N7O2 |
![Plerixafor Impurity A](/) |
Plerixafor Impurity A |
|
|
![Ceftazidime Impurity G](/CAS/20210305/GIF/138829-73-9.gif) |
Ceftazidime Impurity G |
138829-73-9 |
C11H14N4O5S |
![Vonoprazan Impurity 6](/) |
Vonoprazan Impurity 6 |
|
|
![Umeclidinium Bromide Impurity 4](/CAS/20210111/GIF/869112-31-2.gif) |
Umeclidinium Bromide Impurity 4 |
869112-31-2 |
C22H28BrNO2 |
![Deschloro Etoricoxib](/) |
Deschloro Etoricoxib |
|
|
![Cefazolin impurity B](/CAS/20211123/GIF/1798004-55-3.gif) |
Cefazolin impurity B |
1798004-55-3 |
C16H20N4O4S3.Na |
![5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide](/CAS/20200611/GIF/1632463-24-1.gif) |
5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide |
1632463-24-1 |
C38H36Cl2N6O10S2 |
![Rivaroxaban Impurity 16](/) |
Rivaroxaban Impurity 16 |
|
|
![Topiroxostat Impurity 3](/) |
Topiroxostat Impurity 3 |
|
|
![Diroxide Impurity 4](/) |
Diroxide Impurity 4 |
|
|
![(R,E)-4-((3-(3-(diisopropylamino)-1-phenylpropyl)-4-hydroxybenzyl)oxy)-4-oxobut-2-enoic acid](/CAS/20200331/GIF/CB23129542.gif) |
(R,E)-4-((3-(3-(diisopropylamino)-1-phenylpropyl)-4-hydroxybenzyl)oxy)-4-oxobut-2-enoic acid |
|
C26H33NO5 |
![Flomoxef Impurity 2](/CAS/20200515/GIF/1208982-59-5.gif) |
Flomoxef Impurity 2 |
1208982-59-5 |
C32H30N6O7S |
![Lincomycin impurity B](/) |
Lincomycin impurity B |
|
|
![Olsalazine Impurity B](/) |
Olsalazine Impurity B |
|
|
![Parecoxib sodium Impurity 32](/) |
Parecoxib sodium Impurity 32 |
|
|
![Rosuvastatin Impurity 39](/) |
Rosuvastatin Impurity 39 |
|
|
![Tofacitinib Impurity 95](/) |
Tofacitinib Impurity 95 |
|
|
![Vildagliptin Impurity ZA4](/) |
Vildagliptin Impurity ZA4 |
|
|
![Valsartan Impurity 1](/CAS/20180629/GIF/914465-68-2.gif) |
Valsartan Impurity 1 |
914465-68-2 |
C19H21N5O |
![Ethanone, 1-[3,5-bis(phenylmethoxy)phenyl]-2-[(1,1-dimethylethyl)(phenylmethyl)amino]-, sulfate (1:1)](/CAS/20211123/GIF/52144-93-1.gif) |
Ethanone, 1-[3,5-bis(phenylmethoxy)phenyl]-2-[(1,1-dimethylethyl)(phenylmethyl)amino]-, sulfate (1:1) |
52144-93-1 |
C33H37NO7S |
![2-(((3aS,4R,6S,6aR)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol](/CAS/20180702/GIF/CB23143889.gif) |
2-(((3aS,4R,6S,6aR)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
|
C17H27ClN4O4S |
![Clindamycin impurity](/CAS/20211123/GIF/198080-64-7.gif) |
Clindamycin impurity |
198080-64-7 |
C18H32N2O5S |
![Digoxin impurity](/) |
Digoxin impurity |
|
|
![Lamivudine impurity](/) |
Lamivudine impurity |
|
|
![Levothyroxine Sodium impurity](/CAS/20210111/GIF/27566-09-2.gif) |
Levothyroxine Sodium impurity |
27566-09-2 |
C14H21NO4 |
![Dexchlorpheniramine impurity](/CAS/20210305/GIF/73775-50-5.gif) |
Dexchlorpheniramine impurity |
73775-50-5 |
C12H15ClN2 |
![6-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]-oxazin-3-one](/CAS/20180702/GIF/869478-11-5.gif) |
6-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]-oxazin-3-one |
869478-11-5 |
C17H16ClNO4 |
![trans-アポビンカミン酸エチル](/CAS/20210111/GIF/77549-94-1.gif) |
trans-アポビンカミン酸エチル |
77549-94-1 |
C22H26N2O2 |
![Dolutegravir Impurity 2](/) |
Dolutegravir Impurity 2 |
|
|
![Lesinurad Impurity J](/CAS/20180808/GIF/1210330-64-5.gif) |
Lesinurad Impurity J |
1210330-64-5 |
C14H10BrN3O2S |
![Neratinib Impurity 4](/CAS/20211123/GIF/1144516-18-6.gif) |
Neratinib Impurity 4 |
1144516-18-6 |
C31H32ClN6O3+ |
![Linagliptin Impurity C](/CAS/20210111/GIF/1791405-13-4.gif) |
Linagliptin Impurity C |
1791405-13-4 |
C15H20N6O2 |
![1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl-](/CAS/20180808/GIF/849221-94-9.gif) |
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl- |
849221-94-9 |
C28H25N3O5 |
![methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/57430-34-9.gif) |
methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
57430-34-9 |
C22H28N2O4 |
![(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]ethanone](/CAS/20180527/GIF/1288338-95-3.gif) |
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]ethanone |
1288338-95-3 |
C24H24N6O2 |
![Amlodipine Impurity 17](/CAS/20180702/GIF/CB23159167.gif) |
Amlodipine Impurity 17 |
|
C26H31ClN2O8S |
![Edoxaban Impurity 12 (1R,2R,4S)](/) |
Edoxaban Impurity 12 (1R,2R,4S) |
|
|
![Rivaroxaban Impurity 26](/CAS/20210111/GIF/1838133-00-8.gif) |
Rivaroxaban Impurity 26 |
1838133-00-8 |
C23H21Cl2N3O5S2 |
![Erlotinib](/CAS/20200611/GIF/938185-06-9.gif) |
Erlotinib |
938185-06-9 |
C16H11N3O2 |
![methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20180808/GIF/18374-18-0.gif) |
methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
18374-18-0 |
C21H26N2O3 |
![4-[4-[4-(2-オキソ-1,2-ジヒドロキノリン-7-イルオキシ)ブチル]ピペラジノ]ベンゾ[b]チオフェン1-オキシド](/CAS/20200611/GIF/1191900-51-2.gif) |
4-[4-[4-(2-オキソ-1,2-ジヒドロキノリン-7-イルオキシ)ブチル]ピペラジノ]ベンゾ[b]チオフェン1-オキシド |
1191900-51-2 |
C25H27N3O3S |
![Cabozantinib Impurity H](/) |
Cabozantinib Impurity H |
|
|
![Clopidogrel Impurity 11](/CAS/20180629/GIF/CB23166437.gif) |
Clopidogrel Impurity 11 |
|
C15H14ClNO2S |
![Medetomidine Impurity 3](/CAS/20180808/GIF/104245-83-2.gif) |
Medetomidine Impurity 3 |
104245-83-2 |
C10H13Cl |
![(7S)-3-(ヒドロキシメチル)-7-[[(2-チエニル)アセチル]アミノ]-7-メトキシセファム-3-エン-4-カルボン酸](/CAS/GIF/54333-94-7.gif) |
(7S)-3-(ヒドロキシメチル)-7-[[(2-チエニル)アセチル]アミノ]-7-メトキシセファム-3-エン-4-カルボン酸 |
54333-94-7 |
C15H16N2O6S2 |
![ビス(ジメチルカルバミン酸)5-アセチル-1,3-フェニレン](/CAS/GIF/81732-48-1.gif) |
ビス(ジメチルカルバミン酸)5-アセチル-1,3-フェニレン |
81732-48-1 |
C14H18N2O5 |
![Oseltamivir Impurity L](/) |
Oseltamivir Impurity L |
|
|
![5-クロロチオフェン-3-カルボン酸](/CAS/GIF/36157-42-3.gif) |
5-クロロチオフェン-3-カルボン酸 |
36157-42-3 |
C5H3ClO2S |
![(S)-1-[(4-クロロフェニル)フェニルメチル]ピペラジン](/CAS/GIF/439858-21-6.gif) |
(S)-1-[(4-クロロフェニル)フェニルメチル]ピペラジン |
439858-21-6 |
C17H19ClN2 |
![2,8-ジクロロ-5,6-ジヒドロ-11H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-オン](/CAS/GIF/133330-61-7.gif) |
2,8-ジクロロ-5,6-ジヒドロ-11H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン-11-オン |
133330-61-7 |
C14H9Cl2NO |
![2-イソプロピル-6-プロピルフェノール](/CAS/GIF/74663-48-2.gif) |
2-イソプロピル-6-プロピルフェノール |
74663-48-2 |
C12H18O |
![3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル](/CAS/GIF/20850-49-1.gif) |
3,4-ジメトキシ-α-(1-メチルエチル)ベンゼンアセトニトリル |
20850-49-1 |
C13H17NO2 |
![4-[4-[4-[4-[[2-(2,4-ジクロロフェニル)-2-(1H-1,2,4-トリアゾール-1-イルメチル)-1,3-ジオキソラン-4-イル]メトキシ]フェニル]-1-ピペラジニル]フェニル]-2,4-ジヒドロ-2-(2-ヒドロキシ-1-メチルプロピル)-3H-1,2,4-トリアゾール-3-オン](/CAS/GIF/112559-91-8.gif) |
4-[4-[4-[4-[[2-(2,4-ジクロロフェニル)-2-(1H-1,2,4-トリアゾール-1-イルメチル)-1,3-ジオキソラン-4-イル]メトキシ]フェニル]-1-ピペラジニル]フェニル]-2,4-ジヒドロ-2-(2-ヒドロキシ-1-メチルプロピル)-3H-1,2,4-トリアゾール-3-オン |
112559-91-8 |
C35H38Cl2N8O5 |
![1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE](/CAS/GIF/170569-87-6.gif) |
1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE |
170569-87-6 |
C16H12F3N3O2S |
![N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide](/CAS/20200401/GIF/1038972-16-5.gif) |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
1038972-16-5 |
C13H18N4O3 |
![(R)-SN-38](/CAS/GIF/647852-82-2.gif) |
(R)-SN-38 |
647852-82-2 |
C22H20N2O5 |
![5'-デオキシ-5-フルオロ-N-[(3-メチルブトキシ)カルボニル]シチジン](/CAS/GIF/162204-30-0.gif) |
5'-デオキシ-5-フルオロ-N-[(3-メチルブトキシ)カルボニル]シチジン |
162204-30-0 |
C15H22FN3O6 |
![4-[(2,3-Dihydro-5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine Hydrochloride](/CAS2/GIF/1034439-57-0.gif) |
4-[(2,3-Dihydro-5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine Hydrochloride |
1034439-57-0 |
C24H32ClNO2 |
![2-メトキシ-5-スルファモイルベンズアミド](/CAS/GIF/52395-25-2.gif) |
2-メトキシ-5-スルファモイルベンズアミド |
52395-25-2 |
C8H10N2O4S |
![PIPERIDINE-3-CARBOXYLIC ACID (2,6-DIMETHYL-PHENYL)-AMIDE](/StructureFile/ChemBookStructure4/GIF/CB8202154.gif) |
PIPERIDINE-3-CARBOXYLIC ACID (2,6-DIMETHYL-PHENYL)-AMIDE |
337488-90-1 |
C14H20N2O |
![N-Desmethyl Citalopram-d4 Oxalate](/CAS/20211123/GIF/62498-68-4.gif) |
N-Desmethyl Citalopram-d4 Oxalate |
62498-68-4 |
C21H21FN2O5 |
![2-エトキシ-6-ニトロ-9-アクリジンアミン](/CAS/GIF/20304-70-5.gif) |
2-エトキシ-6-ニトロ-9-アクリジンアミン |
20304-70-5 |
C15H13N3O3 |
![4-O-カルボキシメチル-21-デオキシ-20-ヒドロキシ-21-オキソリファマイシン](/CAS/20211123/GIF/15271-73-5.gif) |
4-O-カルボキシメチル-21-デオキシ-20-ヒドロキシ-21-オキソリファマイシン |
15271-73-5 |
C39H47NO15 |
![3',4'-ジメトキシ-α-メチルプロピオフェノン](/CAS/GIF/14046-55-0.gif) |
3',4'-ジメトキシ-α-メチルプロピオフェノン |
14046-55-0 |
C12H16O3 |